The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
Open accessAbstract
The cancer chemopreventive properties of selenium compounds are well documented, yet little is known of the mechanism(s) by which these agents inhibit carcinogenesis. We show that selenium in the form of selenomethionine (SeMet) can activate the p53 tumor suppressor protein by a redox mechanism that requires the redox factor Ref1. Assays to measure direct reduction/oxidation of p53 showed a SeMet-dependent response that was blocked by a dominant–negative Ref1. By using a peptide containing only p53 cysteine residues 275 and 277, we demonstrate the importance of these residues in the SeMet-induced response. SeMet induced sequence-specific DNA binding and transactivation by p53. Finally, cellular responses to SeMet were determined in mouse embryo fibroblasts wild-type or null for p53 genes. The evidence suggests that the DNA repair branch of the p53 pathway was activated. The central relevance of DNA repair to cancer prevention is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Clark, L. (1996) · JAMA · doi:10.1001/jama.276.24.1957 · Cited by 2,719
[21] Thioredoxin and thioredoxin reductase
Holmgren, A., & Bjornstedt, M. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)52023-6 · Cited by 941
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 771
Hwang, B. J., Ford, J. M., Hanawalt, P. C., & Chu, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.424 · Cited by 581
Evans, A. R., Limp-Foster, M., & Kelley, M. R. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00046-x · Cited by 532
Self-citationDisruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan, S., Smith, M. L., Rivet, D. J., Duba, D. E., Zhan, Q., Kohn, K. W., Fornace, A. J., & O'Connor, P. M. (1995) · PubMed · Cited by 490
Self-citationIdentification of redox/repair protein Ref-1 as a potent activator of p53.
Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., & Prives, C. (1997) · Genes & Development · doi:10.1101/gad.11.5.558 · Cited by 481
Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C., Hanawalt, P. C., & Fornace, A. J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3705-3714.2000 · Cited by 432
Self-citationThioredoxin-dependent Redox Regulation of p53-mediated p21 Activation
Ueno, M., Masutani, H., Arai, R. J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J., & Nikaido, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35809 · Cited by 428
Cited by
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
p53 in the DNA–Damage–Repair Process
Williams, A. B., & Schumacher, B. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026070 · Cited by 835
ROS and p53: A versatile partnership
Liu, B., Chen, Y., & St. Clair, D. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.011 · Cited by 830
Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., & Aggarwal, B. B. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4414 · Cited by 732
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
Leslie, N. R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg513 · Cited by 616
Selenium and its relationship to cancer: an update
Whanger, P. D. (2004) · British Journal of Nutrition · doi:10.1079/bjn20031015 · Cited by 613
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
The role of p53 in determining sensitivity to radiotherapy
Gudkov, A. V., & Komarova, E. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc992 · Cited by 572
p53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544
The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme
Tell, G., Quadrifoglio, F., Tiribelli, C., & Kelley, M. R. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2194 · Cited by 516
Self-citationToxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds
Nogueira, C. W., & Rocha, J. B. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0720-3 · Cited by 477
Selenium-Dependent Antioxidant Enzymes: Actions and Properties of Selenoproteins
Zoidis, E., Seremelis, I., Kontopoulos, N., & Danezis, G. (2018) · Antioxidants · doi:10.3390/antiox7050066 · Cited by 473
Free Radicals in Cross Talk Between Autophagy and Apoptosis
Kaminskyy, V. O., & Zhivotovsky, B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5746 · Cited by 412
Arsenic and selenium toxicity and their interactive effects in humans
Sun, H.-J., Rathinasabapathi, B., Wu, B., Luo, J., Pu, L.-P., & Ma, L. Q. (2014) · Environment International · doi:10.1016/j.envint.2014.04.019 · Cited by 405
Selenium and brain function: a poorly recognized liaison
Schweizer, U., Bräuer, A. U., Köhrle, J., Nitsch, R., & Savaskan, N. E. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.03.004 · Cited by 343
On the potential of thioredoxin reductase inhibitors for cancer therapy
Urig, S., & Becker, K. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.004 · Cited by 337
Selenium: a double-edged sword for defense and offence in cancer
Brozmanová, J., Mániková, D., Vlčková, V., & Chovanec, M. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0595-8 · Cited by 333
Tumor suppressor genes and ROS: complex networks of interactions
Vurusaner, B., Poli, G., & Basaga, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.035 · Cited by 293
Toxicology and risk assessment of coumarin: Focus on human data
Abraham, K., Wöhrlin, F., Lindtner, O., Heinemeyer, G., & Lampen, A. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900281 · Cited by 292
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation
Wang, K., Zhang, T., Dong, Q., Nice, E. C., Huang, C., & Wei, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.50 · Cited by 288
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target
Fishel, M. L., & Kelley, M. R. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.04.005 · Cited by 278
Self-citationSinha, R., & El-Bayoumy, K. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481614 · Cited by 265
Bhakat, K. K., Mantha, A. K., & Mitra, S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2198 · Cited by 255
Brazil nuts and associated health benefits: A review
Yang, J. (2009) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2009.05.019 · Cited by 253
Biological effects of space radiation and development of effective countermeasures
Kennedy, A. R. (2014) · Life Sciences in Space Research · doi:10.1016/j.lssr.2014.02.004 · Cited by 188
Reactivation of mutant p53: molecular mechanisms and therapeutic potential
Selivanova, G., & Wiman, K. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210295 · Cited by 186
Selenius, M., Rundlöf, A.-K., Olm, E., Fernandes, A. P., & Björnstedt, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2884 · Cited by 170
The role of tumor suppressor p53 in the antioxidant defense and metabolism
Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157
“p53 can be also activated via redox-dependent mechanisms involving redox factor Ref1 (Seo et al., 2002).”
BackgroundBrash, D. E., & Havre, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232574399 · Cited by 108
Watching the watcher: Regulation of p53 by mitochondria
Holley, A. K., & St Clair, D. K. (2009) · Future Oncology · doi:10.2217/14796694.5.1.117 · Cited by 75
Selenomethionine protects against adverse biological effects induced by space radiation
Kennedy, A. R., Ware, J. H., Guan, J., Donahue, J. J., Biaglow, J. E., Zhou, Z., Stewart, J., Vazquez, M., & Wan, X. S. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.010 · Cited by 67
Seo, Y. R., & Jung, H. J. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.64 · Cited by 56
Self-citationFavrot, C., Beal, D., Blouin, E., Leccia, M. T., Roussel, A. M., & Rachidi, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5895439 · Cited by 36
Protective effects of l-selenomethionine on space radiation induced changes in gene expression
Stewart, J., Ko, Y. H., & Kennedy, A. R. (2007) · Radiation and Environmental Biophysics · doi:10.1007/s00411-006-0089-5 · Cited by 14
Metadata
- Authors
- Seo, Y. R., Kelley, M. R., & Smith, M. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-09-30
- Volume
- 99
- Issue
- 22
- Pages
- 14548-14553
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2045786144
- Cited by
- 280
- References
- 40
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.